Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Sarcoma 1 Refractory Solid Tumors 1 Neoplasm Metastasis 1 Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 2 tremelimumab 1 poly ICLC 1 lenvatinib 1 durvalumab 1 balstilimab 1 Peptides 1 Pemetrexed 1 Carboplatin 1 Blood Specimen Collection 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × eribulin × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡